Fundación para la Investigación Biomédica del Hospital Universitario La Paz

• Artículos

Lindholm D, Hagström E, James SK, Becker RC, Cannon CP, Himmelmann A, Katus HA, Maurer G, López-Sendón JL, Steg PG, Storey RF, Siegbahn A, Wallentin L. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding. J Am Heart Assoc. 2017 Apr 14;6(4). pii: e005580. doi: 10.1161/JAHA.117.005580. PubMed PMID: 28411246.

Irazusta FJ, Jiménez-Valero S, Gemma D, Meras P, Galeote G, Sanchez-Recalde A, Rial V, Moreno R, Lopez-Sendon JL. Percutaneous balloon pericardiotomy: Treatment of choice in patients with advanced oncological disease and severe pericardial effusion. Cardiovasc Revasc Med. 2017 Apr 4. pii: S1553-8389(17)30113-6. doi: 10.1016/j.carrev.2017.03.029. [Epub ahead of print] PubMed PMID: 28404226.

Cowie MR, Filippatos GS, Alonso Garcia ML, Anker SD, Baczynska A, Bloomfield DM, Borentain M, Bruins Slot K, Cronin M, Doevendans PA, El-Gazayerly A, Gimpelewicz C, Honarpour N, Janmohamed S, Janssen H, Kim AM, Lautsch D, Laws I, Lefkowitz M, Lopez-Sendon J, Lyon AR, Malik FI, McMurray JJ, Metra M, Figueroa Perez S, Pfeffer MA, Pocock SJ, Ponikowski P, Prasad K, Richard-Lordereau I, Roessig L, Rosano GM, Sherman W, Stough WG, Swedberg K, Tyl B, Zannad F, Boulton C, De Graeff P. New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. Eur J Heart Fail. 2017 Mar 27. doi: 10.1002/ejhf.809. [Epub ahead of print] Review. PubMed PMID: 28345190.

Merás P, Caro J, Trigo E, Irazusta J, López-Sendón JL, Refoyo E. Diagnostic Value of NT-proBNP for Early Identification of Chagas Cardiomyopathy in Non-endemic Areas. Rev Esp Cardiol (Engl Ed). 2017 Feb 23. pii: S1885-5857(16)30427-3. doi: 10.1016/j.rec.2016.12.010. [Epub ahead of print] English, Spanish. PubMed PMID: 28238648.

Irazusta FJ, Ramirez U, Caro-Codon J, Refoyo E, Garrido D, Pinilla I, Mesa JM, Lopez-Sendon JL. Extensive Chest Wall Destruction Secondary to a Large Ventricle Pseudoaneurysm: A Surgical Challenge. Ann Thorac Surg. 2017 Mar;103(3):e227-e229. doi: 10.1016/j.athoracsur.2016.09.007. PubMed PMID: 28219553.

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. J Am Coll Cardiol. 2017 Feb 21;69(7):777-785. doi: 10.1016/j.jacc.2016.11.061. PubMed PMID: 28209218.

Tamargo J, Rosano GM, Delpón E, Ruilope L, López-Sendón J. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes. Int J Cardiol. 2017 Apr 15;233:1-11. doi: 10.1016/j.ijcard.2016.11.124. Epub 2016 Nov 9. Review. PubMed PMID: 28161130.

Ponz de Antonio I, Ruiz Cantador J, González García AE, Oliver Ruiz JM, Sánchez-Recalde Á, López-Sendón JL. Prevalence of Neuroendocrine Tumors in Patients With Cyanotic Congenital Heart Disease. Rev Esp Cardiol (Engl Ed). 2017 Jan 13. pii: S1885-5857(16)30421-2. doi: 10.1016/j.rec.2016.09.036. [Epub ahead of print] English, Spanish. PubMed PMID: 28094126.

Caballero R, Utrilla RG, Amorós I, Matamoros M, Pérez-Hernández M, Tinaquero D, Alfayate S, Nieto-Marín P, Guerrero-Serna G, Liu QH, Ramos-Mondragón R, Ponce-Balbuena D, Herron T, Campbell KF, Filgueiras-Rama D, Peinado R, López-Sendón JL, Jalife J, Delpón E, Tamargo J. Tbx20 controls the expression of the KCNH2 gene and of hERG channels. Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E416-E425. doi: 10.1073/pnas.1612383114. Epub 2017 Jan 3. PubMed PMID: 28049825; PubMed Central PMCID: PMC5255604.

Escobar C, Arceluz M, Montes de Oca R, Mori R, López-Sendón JL, Merino JL. Concomitant Rivaroxaban and Dronedarone Administration in Patients With Nonvalvular Atrial Fibrillation. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):121-122. doi: 10.1016/j.rec.2016.06.018. Epub 2016 Sep 28. English, Spanish. PubMed PMID: 27693025.

• Comunicaciones a Congresos

Universidad Complutense de Madrid. Facultad de Medicina. Departamento de Farmacología

• Artículos

Authors/Task Force Members , Habib G , Lancellotti P , Antunes MJ , Bongiorni MG , Casalta JP , Del Zotti F , Dulgheru R , El Khoury G , Erba PA , Iung B , Miro JM , Mulder BJ , Plonska-Gosciniak E , Price S , Roos-Hesselink J , Snygg-Martin U , Thuny F , Tornos Mas P , Vilacosta I , Zamorano JL. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Aug 29. pii: ehv319. [Epub ahead of print]

Camm AJ, Manolis A, Ambrosio G, Daly C, Komajda M, Lopez de Sa E, Lopez-Sendon JL, Mugelli A, Muggli F, Tamargo J. Unresolved issues in the management of chronic stable angina. Int J Cardiol. 2015 Dec 15;201:200-7. doi: 10.1016/j.ijcard.2015.08.045.

Daimi H, Lozano-Velasco E, Haj Khelil A, Chibani JB, Barana A, Amorós I, González de la Fuente M, Caballero R, Aranega A, Franco D. Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice. Heart Rhythm. 2015 Jun;12(6):1333-42. doi: 10.1016/j.hrthm.2015.02.018.

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur Heart J. 2015 May 6. pii: ehv161. [Epub ahead of print] Review.

Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015 May;71(5):549-67.

Tamargo J, Caballero R, Delpón E. Cancer chemotherapy and cardiac arrhythmias: a review. Drug Saf. 2015 Feb;38(2):129-52.

Tamargo J, Duarte J, Ruilope LM. New Antihypertensive Drugs Under Development. Curr Med Chem. 2015;22(3):305-42

• Comunicaciones a Congresos

Barana A, Matamoros M, Amorós I, Pérez-Hernández M, Núñez M, Filgueiras-Rama d, Caballero R, López-Sendón JL, Tamargo J, Delpón E
A missense mutation in the transciption factor TBX20 gene causes long QT syndrome . Póster (P5945). European Heart Journal 2015;36(Abstract Supplement):1037(P5945)

Fundación para la Investigación Biomédica del Hospital Universitario Puerta de Hierro

• Artículos

Bertomeu-González V, Moreno-Arribas J, Castillo-Castillo J, et al. Etiology and Programming Effects on Shock Efficacy in ICD Recipients. Pacing Clin Electrophysiol. 2015 Oct 9. doi: 10.1111/pace.12765.

Selga E, Campuzano O, Pinsach-Abuin ML, et al. Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort. PLoS One. 2015 Jul 14;10(7):e0132888.

Guzzo-Merello G, Dominguez F, González-López E, et al. Malignant ventricular arrhythmias in alcoholic cardiomyopathy. Int J Cardiol. 2015 Nov 15;199:99-105.

Leclercq C, Sadoul N, Mont L, et al; SEPTAL CRT Study investigators. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study. Eur Heart J. 2015 Sep 15. pii: ehv422.

Fontenla A, Castro L, Julia J, Arribas F. When is an Outflow Tract PCV Completely Ablated? J Cardiovasc Electrophysiol. 2015 Jul;26(7):814-5.

García-Lunar I, Castro-Urda V, Toquero-Ramos J, Mingo-Santos S, Moñivas-Palomero V, Daniela Mitroi C, et al. Ventricular Arrhythmias in Super-responders to Cardiac Resynchronization Therapy. Rev Esp Cardiol. 2014 Jun 4.

Riuró H, Campuzano O, Berne P, Arbelo E, Iglesias A, Pérez-Serra A, Coll-Vidal M, Partemi S, Mademont-Soler I, Picó F, Allegue C, Oliva A, Gerstenfeld E, Sarquella-Brugada G, Castro-Urda V, Fernández-Lozano I, Mont L, Brugada J, Scornik FS, Brugada R. Genetic analysis, in silico prediction, and family segregation in long QT syndrome. Eur J Hum Genet. 2015 Jan;23(1):79-85.

Selga E, Campuzano O, Pinsach-Abuin ML, Pérez-Serra A, Mademont-Soler I, Riuró H, Picó F, Coll M, Iglesias A, Pagans S, Sarquella-Brugada G, Berne P, Benito B, Brugada J, Porres JM, López Zea M, Castro-Urda V, Fernández-Lozano I, Brugada R. Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort. PLoS One. 2015 Jul 14;10(7):e0132888.

• Comunicaciones a Congresos

Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal

• Artículos

Pison L, Potpara TS, Chen J, et al; Scientific Initiative Committee, European Heart Rhythm Association. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Europace. 2015 Apr;17(4):642-6.

Potpara TS, Pison L, Larsen TB, et al; Scientific Initiatives Committee, and European Heart Rhythm Association. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey. Europace. 2015 Mar;17(3):468-72.

Chen J, Hocini M, Larsen TB, et al; Scientific Initiative Committee, European Heart Rhythm Association. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey. Europace. 2015 Feb;17(2):314-7.

De Ferrari GM, Maier LS, Mont L, et al; RAFFAELLO Investigators. Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. Heart Rhythm. 2015;12(5):872-8.

Sciaraffia E, Dagres N, Hernandez-Madrid A, et al. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey. Europace. 2015 Jan;17(1):148-51.

Larsen TB, Potpara T, Dagres N, et al; Scientific Initiative Committee, European Heart Rhythm Association. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey. Europace. 2015 May;17(5):819-24.

Anguera I, Dallaglio P, Macías R, et al. Long-Term Outcome After Ablation of Right Atrial Tachyarrhythmias After the Surgical Repair of Congenital and Acquired Heart Disease. Am J Cardiol. 2015 Jun 15;115(12):1705-13.

Hernandez-Madrid A, Chen J, Potpara T, et al; Scientific Initiative Committee, European Heart Rhythm Association. Management of paediatric arrhythmias in Europe: authors' reply. Europace. 2015 May 19. pii: euv093.

Rodríguez Muñoz D, Franco Díez E, Moreno J, et al. Wireless Ultrasound Guidance for Femoral Venous Cannulation in Electrophysiology: Impact on Safety, Efficacy, and Procedural Delay. Pacing Clin Electrophysiol. 2015 Sep;38(9):1058-65.

Estner HL, Grazia Bongiorni M, Chen J, et al; Scientific Initiative Committee, European Heart Rhythm Association. Use of fluoroscopy in clinical electrophysiology in Europe: results of the European Heart Rhythm Association Survey. Europace. 2015 Jul;17(7):1149-52.

Chen J, Todd DM, Proclemer A, et al; Conducted by the Scientific Initiative Committee, European Heart Rhythm Association; Conducted by the Scientific Initiative Committee European Heart Rhythm Association. Management of patients with ventricular tachycardia in Europe: results of the European Heart Rhythm Association survey. Europace. 2015 Aug;17(8):1294-9.

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015 Aug 29. pii: ehv316.

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015 Aug 29. pii: euv319.

Todd D, Hernandez-Madrid A, Proclemer A, et al; Scientific Initiative Committee, European Heart Rhythm Association; Scientific Initiative Committee European Heart Rhythm Association. How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey. Europace. 2015 Sep;17(9):1449-53.

Franco E, Matia R, Rodriguez Muñoz D, et al. Atypical Response to Diagnostic Maneuvers in a Narrow QRS Tachycardia: What is the Mechanism? Pacing Clin Electrophysiol. 2015 Sep 28. doi: 10.1111/pace.12755.

Chen J, Dagres N, Hocini M, Fauchier L, et al; Conducted by the Scientific Initiatives Committee of the European Heart Rhythm Association (EHRA); Conducted by the Scientific Initiatives Committee of the European Heart Rhythm Association EHRA. Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II. Europace. 2015 Oct 12. pii: euv315.

Dagres N, Bongiorni MG, Larsen TB, et al; Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association; Conducted by the Scientific Initiatives Committee European Heart Rhythm Association. Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace. 2015 Oct;17(10):1596-600.

Dallaglio PD, Anguera I, Jiménez-Candil J, et al. Impact of previous cardiac surgery on long-term outcome of cavotricuspid isthmus-dependent atrial flutter ablation. Europace. 2015 Oct 27. pii: euv237.

Mont L, Bisbal F, Hernández-Madrid A, Pérez-Castellano N, Viñolas X, Arenal A, et al; SARA investigators. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501-7.

Sciaraffia E, Dagres N, Hernandez-Madrid A, Proclemer A, Todd D, Blomström-Lundqvist C. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey. Europace. 2015 Jan;17(1):148-51

Hernandez-Madrid A, Chen J, Potpara T, Pison L, Bjerregaard Larsen T, Estner HL, Todd D, Grazia Bongiorni M, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Management of paediatric arrhythmias in Europe : authors' reply. Europace. 2015 May 19. pii: euv093.

• Comunicaciones a Congresos
  

Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre

• Artículos

Arribas F, Auricchio A, Boriani G, Brugada J, Deharo JC, Hindriks G, et al. Statistics on the use of cardiacelectronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA). Europace. 2014;16Suppl 1:i1-78.

de Riva-Silva M, López-Gil M, Salgado-Aranda R, Fontenla-Cerezuela A, Salguero-Bodes R, Arribas-Ynsaurriaga F. Value of intraoperative electrical parameters obtained during implantation of cardiac resynchronization therapy devices for the prediction of reverse remodeling. Rev Esp Cardiol (Engl Ed). 2014 Oct;67(10):855-7.

López-Gil M, Salgado R, Merino JL, Datino T, Figueroa J, Arenal A, et al. Cavo-tricuspid isthmus radiofrequency ablation using a novel remote navigation catheter system in patients with typical atrial flutter. Europace. 2014;16:558-62.

Fontenla A, López Gil M, Martínez Ferrer J, Alzueta J, Fernández Lozano I, Viñolas X, et al. Clinical profile and incidence of ventricular arrhythmia in patients undergoing defibrillator generator replacement in Spain. Rev Esp Cardiol. 2014;67:986-92

Molina-Martin de Nicolas J, Fontenla Cerezuela A, Diaz Anton B, Rubio Alonso B, Salgado Aranda R, Salguero Bodes R, Lopez Gil M, Arribas Ynsaurriaga F. A particular malignant case of untreatable ventricular arrhythmias in arrhythmogenic cardiomyopathy. Int J Cardiol. 2015 Mar 1;182:307-8.

Román Barba V, Domínguez Manzano P, Toral Vázquez B, López-Gil M. Familiar severe hypertrophic cardiomyopathy and sudden cardiac death. An Pediatr (Barc). 2015 Jun 22. pii: S1695-4033(15)00228-3.

• Comunicaciones a Congresos

Fundación para la Investigación Biomédica del Hospital Universitario Clinico San Carlos

• Artículos

Toniolo M, Estrada A, Filgueiras-Rama D, et al. Revolving thrombus within the left atrium at atrial fibrillation ablation. Herzschrittmacherther Elektrophysiol. 2015 Mar;26(1):54-5.

Filgueiras-Rama D, de Torres-Alba F, Castrejón-Castrejón S, et al. Utility of intracardiac echocardiography for catheter ablation of complex cardiac arrhythmias in a medium-volume training center. Echocardiography. 2015 Apr;32(4):660-70.

Filgueiras-Rama D, Calvo CJ, Salvador-Montañés Ó, et al. Spectral analysis-based risk score enables early prediction of mortality and cerebral performance in patients undergoing therapeutic hypothermia for ventricular fibrillation and comatose status. Int J Cardiol. 2015 May 1;186:250-8.

Anguera I, Dallaglio P, Martínez-Ferrer J, et al. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study. J Cardiovasc Electrophysiol. 2015 Jul;26(7):774-82.

Ringenberg J, Deo M, Filgueiras-Rama D, Pizarro G, Ibañez B, Peinado R, et al. Effects of fibrosis morphology on reentrant ventricular tachycardia inducibility and simulation fidelity in patient-derived models. Clin Med Insights Cardiol. 2014 Sep 25;8(Suppl 1):1-13.

Páez JL, Doiny D, Estrada A, Figueroa J, Filgueiras-Rama D, Merino JL. Dronedarone: an option in the treatment of ventricular arrhythmias. Rev Esp Cardiol (Engl Ed). 2013 Aug;66(8):668-70.

Filgueiras-Rama D, Calvo CJ, Salvador-Montañés Ó, Cádenas R, Ruiz-Cantador J, Armada E, Rey JR, Merino JL, Peinado R, Pérez-Castellano N, Pérez-Villacastín J, Quintanilla JG, Jiménez S, Castells F, Chorro FJ, López-Sendón JL, Berenfeld O, Jalife J, López de Sá E, Millet J. Spectral analysis-based risk score enables early prediction of mortality and cerebral performance in patients undergoing therapeutic hypothermia for ventricular fibrillation and comatose status. Int J Cardiol. 2015 May 1;186:250-8.

Filgueiras-Rama D, de Torres-Alba F, Castrejón-Castrejón S, Estrada A, Figueroa J, Salvador-Montañés Ó, López T, Moreno-Yanguela M, López Sendón JL, Merino JL. Utility of intracardiac echocardiography for catheter ablation of complex cardiac arrhythmias in a medium-volume training center. Echocardiography. 2015 Apr;32(4):660-70.

Cervigón R, Moreno J, García-Quintanilla J, Pérez-Villacastín J, Castells F. Entropy at the right atrium as a predictor of atrial fibrillation recurrence outcome after pulmonary vein ablation. Biomed Tech (Berl). 2015 Jun 24. [Epub ahead of print]

Quintanilla JG, Moreno J, Archondo T, Usandizaga E, Molina-Morúa R, Rodríguez-Bobada C, González P, García-Torrent MJ, Filgueiras-Rama D, Pérez-Castellano N, Macaya C, Pérez-Villacastín J. Increased intraventricular pressures are as harmful as the electrophysiological substrate of heart failure in favoring sustained reentry in the swine heart. Heart Rhythm. 2015 May 16. pii: S1547-5271(15)00619-0.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators). Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. Heart Rhythm. 2015 May;12(5):872-8.

• Comunicaciones a Congresos

Fundación para la Investigación Biomédica del HCSC. Unidad de Investigación Cardiovascular

• Artículos

Islas F, Olmos C, Vieira C, De Agustín JA, Marcos-Alberca P, Saltijeral A, Almería C, Rodrigo JL, García Fernández MA, Macaya C, Pérez de Isla L. Thromboembolic Risk in Atrial Fibrillation: Association between Left Atrium Mechanics and Risk Scores. A Study Based on 3D Wall-Motion Tracking Technology. Echocardiography. 2015;32(4):644-53.